The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection

被引:43
|
作者
Lefrère, JJ
Roudot-Thoraval, F
Mariotti, M
Thauvin, M
Lerable, J
Salpétrier, J
Morand-Joubert, L
机构
[1] Hop St Antoine, Inst Natl Transfus Sanguine, Virol Lab, F-75571 Paris, France
[2] Hop Henri Mondor, Dept Sante Publ, F-94010 Creteil, France
来源
JOURNAL OF INFECTIOUS DISEASES | 1998年 / 177卷 / 06期
关键词
D O I
10.1086/515308
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A cohort of 103 human immunodeficiency virus type 1 (HIV-l)-infected persons with well-defined dates of seroconversion were studied to determine whether baseline plasma HIV RNA loads 6-12 months after seroconversion have prognostic value. Baseline plasma virus loads had predictive value for the disease-free survival rate and for the survival rate. The level of baseline HIV RNA also had a strong negative predictive value for the CD4(+) T cell count during the fifth year of infection: A baseline load >5 log was predictive of a CD4(+) T cell count <500/mm(3) 5 years after infection. Baseline HIV RNA load was a CD4(+) T cell-independent predictor of progression to death. The major finding was that the disease outcome for HIV-l-infected persons is already determined during the first year of infection.
引用
收藏
页码:1541 / 1548
页数:8
相关论文
共 50 条
  • [41] Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection
    Kaufmann, GR
    Cunningham, P
    Kelleher, AD
    Zaunders, J
    Carr, A
    Vizzard, J
    Law, M
    Cooper, DA
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06): : 1812 - 1815
  • [42] Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection
    Loomis-Price, LD
    Cox, JH
    Mascola, JR
    VanCott, TC
    Michael, NL
    Fouts, TR
    Redfield, RR
    Robb, ML
    Wahren, B
    Sheppard, HW
    Birx, DL
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05): : 1306 - 1316
  • [43] Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
    Musey, L
    Hughes, J
    Schacker, T
    Shea, T
    Corey, L
    McElrath, MJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (18): : 1267 - 1274
  • [44] Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand
    Kilmarx, PH
    Limpakarnjanarat, K
    Kaewkungwal, J
    Srismith, R
    Saisorn, S
    Uthaivoravit, W
    Young, NL
    Mastro, TD
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05): : 1598 - 1606
  • [45] Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection
    Ida, S
    Tachikawa, N
    Nakajima, A
    Daikoku, M
    Yano, M
    Kikuchi, Y
    Yasuoka, A
    Kimura, S
    Oka, S
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) : 379 - 385
  • [46] Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS
    Carl, S
    Greenough, TC
    Krumbiegel, M
    Greenberg, M
    Skowronski, J
    Sullivan, JL
    Kirchhoff, F
    JOURNAL OF VIROLOGY, 2001, 75 (08) : 3657 - 3665
  • [47] Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India
    Mehendale, SM
    Bollinger, RC
    Kulkarni, SS
    Stallings, RY
    Brookmeyer, RS
    Kulkarni, SV
    Divekar, AD
    Gangakhedkar, RR
    Joshi, SN
    Risbud, AR
    Thakar, MA
    Mahajan, BA
    Kale, VA
    Ghate, MV
    Gadkari, DA
    Quinn, TC
    Paranjape, RS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (16) : 1175 - 1179
  • [48] Skin disease as the first manifestation of human immunodeficiency virus infection in Tanzania
    Leppard, BJ
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 1 - 2
  • [49] PERSISTENT HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ANTIGENEMIA IN CHILDREN CORRELATES WITH DISEASE PROGRESSION
    EPSTEIN, LG
    BOUCHER, CAB
    MORRISON, SH
    CONNOR, EM
    OLESKE, JM
    LANGE, JMA
    VANDERNOORDAA, J
    BAKKER, M
    DEKKER, J
    SCHERPBIER, H
    VANDENBERG, H
    BOER, K
    GOUDSMIT, J
    PEDIATRICS, 1988, 82 (06) : 919 - 924
  • [50] Human SMOOTHENED inhibits human immunodeficiency virus type 1 infection
    Yoshida, Takeshi
    Hamano, Akiko
    Ueda, Asuka
    Takeuchi, Hiroaki
    Yamaoka, Shoji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 132 - 138